{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:59:59Z","timestamp":1778590799901,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jiac.2020.03.001","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T17:23:21Z","timestamp":1585848201000},"page":"775-779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In\u00a0vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018\u201319 season: Comparison with the 2010\u201311 to 2017\u201318 seasons"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-4231","authenticated-orcid":false,"given":"Hideyuki","family":"Ikematsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8412-8463","authenticated-orcid":false,"given":"Naoki","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Bando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seizaburo","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.03.001_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016\u20132017","volume":"157","author":"Lackenby","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiac.2020.03.001_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jiac.2019.04.007","article-title":"In\u00a0vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017\u201318 season: comparison with the 2010\u201311 to 2016\u201317 seasons","volume":"25","author":"Ikematsu","year":"2019","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2020.03.001_bib4","doi-asserted-by":"crossref","first-page":"8418e25","DOI":"10.1128\/JVI.77.15.8418-8425.2003","article-title":"Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors","volume":"77","author":"Matrosovich","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2020.03.001_bib5","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JCM.36.10.2990-2995.1998","article-title":"Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses","volume":"36","author":"Stockton","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2020.03.001_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jviromet.2014.04.016","article-title":"Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages","volume":"205","author":"Nakauchi","year":"2014","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.jiac.2020.03.001_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity","volume":"53","author":"Yamashita","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.03.001_bib8","first-page":"369","article-title":"Meeting of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012","volume":"39","author":"World Health Organization","year":"2012","journal-title":"Wkly Eepidemiol Rec"},{"key":"10.1016\/j.jiac.2020.03.001_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/irv.12624","article-title":"Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan","volume":"13","author":"Chong","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jiac.2020.03.001_bib10","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.03.001_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbrc.2012.10.095","article-title":"A\u00a0single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs","volume":"429","author":"Fujisaki","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jiac.2020.03.001_bib12","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/jac\/dkv065","article-title":"Influenza viruses with B\/Yamagata- and B\/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility","volume":"70","author":"Farrukee","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.03.001_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/596311","article-title":"Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children","volume":"48","author":"Stephenson","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.03.001_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/irv.12534","article-title":"Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study","volume":"12","author":"Lina","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jiac.2020.03.001_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/505868","article-title":"A\u00a0comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003\u20132004 and 2004\u20132005 influenza seasons","volume":"43","author":"Kawai","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:59:36Z","timestamp":1761159576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1341321X20300696"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.03.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018\u201319 season: Comparison with the 2010\u201311 to 2017\u201318 seasons","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}